Teva reaches $225m Texas opioid settlement - Globes
Little chance of Teva CEO seeing share price bonus - Globes
Teva misses on Q3 profit and revenue - Globes
Teva boosted as FDA delays generic Copaxone - Globes
Teva: 48 US states agree opioid settlement - Globes
Teva recalls US-made drugs following contamination fears - The Boston Globe
New York jury holds drugmaker Teva liable in opioid crisis - The Boston Globe
Amazon.com | Teva Women's Original Universal Sandal, 90s Multi, 5 | Sport Sandals & Slides
Teva shed 37% of Israel workforce in two years - Globes
Teva acquires Gecko Health Innovations - Globes
Teva Pharmaceutical to pay $523-million to New York State as it looks to move past opioid lawsuits - The Globe and Mail
Teva faces lawsuit from Israel over unpaid Copaxone royalties
Teva Footwear: Who We Are | Teva®
Teva reports heavy losses, sees minimal 2023 growth - Globes
Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
Teva shed 37% of Israel workforce in two years - Globes
Teva receives US clearance for Actavis acquisition - Globes
The change had to be made, Teva's CEO tells "Globes" - Globes
Amazon.com | Teva Men's Katavi 2 Sandal, Black Olive, 7 | Sport Sandals & Slides
Teva concludes US nationwide opioid settlement - Globes
Teva Original Universal Reviews - Trailspace
Teva misses on Q3 profit and revenue - Globes
Teva reaches opioid settlement with West Virginia - Globes
US Congress heaps more misery on Teva - Globes
Teva agrees to tentative $4.25 billion national settlement over opioids - The Boston Globe
Analysts urge M&A for Teva - Globes
Teva's new CEO: There's an opportunity to return to growth - Globes
